Bill
Bill > A06606
NY A06606
NY A06606Penalizes the price gouging of pharmaceuticals; penalty not to exceed one million dollars.
summary
Introduced
03/14/2019
03/14/2019
In Committee
01/08/2020
01/08/2020
Crossed Over
Passed
Dead
12/31/2020
12/31/2020
Introduced Session
2019-2020 General Assembly
Bill Summary
AN ACT to amend the general business law, in relation to the price gouging of pharmaceuticals The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1
AI Summary
This bill amends the general business law of New York to prohibit manufacturers or wholesalers of pharmaceuticals from selling or offering to sell their products at an "unconscionably excessive price." The bill defines "pharmaceuticals" as any compound manufactured for sale as a medicinal drug. The court can determine whether a price is unconscionably excessive based on factors such as the amount of the price excess being extreme or the use of unfair leverage or unconscionable means. The attorney general can seek an injunction and a civil penalty of up to $1 million if a violation is found, and the court can also order restitution to aggrieved consumers.
Committee Categories
Business and Industry
Sponsors (29)
Marcos Crespo (D)*,
Joseph Lentol (D)*,
Charles Barron (D),
Michael Benedetto (D),
Marianne Buttenschon (D),
Robert Carroll (D),
William Colton (D),
Catalina Cruz (D),
Anthony D'Urso (D),
Jeffrey Dinowitz (D),
Steven Englebright (D),
Harvey Epstein (D),
Richard Gottfried (D),
Judy Griffin (D),
Andrew Hevesi (D),
Pamela Hunter (D),
Jonathan Jacobson (D),
Kimberly Jean-Pierre (D),
Michael LiPetri (R),
Michael Montesano (R),
Walter Mosley (D),
Yuh-Line Niou (D),
Félix Ortiz (D),
Victor Pichardo (D),
Karines Reyes (D),
Rebecca Seawright (D),
Jo Anne Simon (D),
Steve Stern (D),
David Weprin (D),
Last Action
enacting clause stricken (on 07/06/2020)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...